Jack Dorsey resigned from Twitter TODAY — his second departure from the company he co-founded, this one voluntary, with a resignation letter arguing against the cult of the founder-CEO itself (“there’s a lot of talk about the importance of a company being ‘founder-led.’ Ultimately I believe that’s severely limiting and a single point of failure” — the man cited SPOF doctrine in his farewell; the archive has never felt more seen by an executive departure). CTO Parag Agrawal inherits the seat, the activist-investor pressure (Elliott’s file has wanted this for years), and the eternal Twitter question: the most culturally load-bearing, financially underperforming platform in the industry (#095’s outrage-optimizer, #196’s deplatforming precedent, #140’s $4.4M-per-word — this archive’s index is substantially a Twitter incident log). Dorsey retreats to Block/Square and his bitcoin evangelism (#216’s Web3 wars lose their most interesting combatant on the anti-VC flank). The file’s read: founder-succession is the least-practiced migration in tech (#203’s Basecamp SPOF clause, #164’s incentive-aligned boards), and Twitter is about to run the experiment with maximum observability. The universe, as is its custom with this platform, will make the results interesting beyond anyone’s intent. (Foreshadowing is a literary device the archive employs only in retrospect. Noted for #220-something.)
The fortnight’s heavier watch item: a new COVID variant — OMICRON, flagged by South African genomic surveillance (whose reward for world-class instrumentation-and-disclosure was immediate travel bans; punishing the best telemetry is anti-incentive design at its civilizational worst, #116’s disclosure-economics file, pandemic edition) — carries a spike-protein mutation profile alarming enough that markets dropped 2-3% on Friday and every pharma team re-opened their variant playbooks. The mRNA platform’s re-targeting speed (#192) is about to get its first true production test. Fifteen days from now this entry’s uncertainty will look either quaint or prescient; the archive files it at the moment of not-knowing, per charter (#171).
Life patch note, the biggest jump yet: I’ve joined a Y-Combinator-backed fintech (W21 batch) to lead platform and DevOps — fully remote, Southeast Asia payments market, seed-round velocity. After a year of edtech’s population-scale pipelines I wanted the other end of the telescope: a company small enough that the platform IS the org chart. The YC universe this blog has rubbernecked since the folding-chair era (#006) is now, absurdly, my employer’s family tree. Week-three findings: startup speed is real, the AWS bill is feral, and the 99.9% SLA I was hired to build currently rests on “we have a status page, mostly.” Perfect. That’s the job.
TIL: variant nomenclature and immune-escape scoring — how mutation counts at receptor-binding sites translate to neutralization concern before lab data exists. Genomic surveillance is the world’s best-designed alerting system currently attached to the world’s worst incentive structure. Fix the pager economics (#205’s availability-debt, planetary edition).